RETROSPECTIVE STUDY TO ASSESS AXILLARY MANAGEMENT AND ONCOLOGICAL OUTCOME AFTER NEOADJUVANT CHEMOTHERAPY FOR BREAST CANCER PATIENTS

Retrospective study to assess axillary management and oncological outcome after neoadjuvant chemotherapy for patients with breast cancer

Axillary Lymph Node Dissection versus Axillary Radiation in Patients with Positive Sentinel Lymph Node Biopsy in Early Breast Cancer

Breast-Conserving Surgery after Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer: Single Institute Experience

Partial Axillary Dissection after Sentinel Lymph Node Biopsy In Clinically Node-Negative Breast Cancer Patients

Evaluation of targeted axillary dissection in node positive locally advanced breast cancer patients with complete pathological response to neoadjuvant chemotherapy

Evaluation of targeted axillary dissection following neoadjuvant therapy for a patient with node-positive breast cancer as initial experience in Ain Shams University Hospitals

ASSESSMENT OF SURGICAL MANAGEMENT OF FEMALE BREAST CANCER PATIENTS AFTER NEOADJUVANT SYSTEMIC THERAPY FOR INVASIVE DUCTAL VERSUS INVASIVE LOBULAR CARCINOMA (T3 STAGE)

Vertical Axillary Incision for Treatment of Breast Outer Quadrants Tumors

SURGICAL MANAGEMENT OF Tx BREAST CANCER: IS BREAST CONSERVATION AN OPTION?